Ali Health has announced the completion of internal trials and the subsequent launch for download of its new AI product, 'Hydrogen Ion', marking its entry into the phase of real-world application. This innovative tool is designed specifically for medical practitioners in both clinical and research settings, with a key focus on delivering responses that are "low on hallucinations and high on evidence-based content." Every piece of information furnished by 'Hydrogen Ion' is backed by credible sources and can be traced back with a single click. As the inaugural realization of Ali Health's proprietary medical large language model capabilities, 'Hydrogen Ion' has garnered favorable responses from physicians during its internal testing phase. It has showcased remarkable precision across a variety of tasks and provides an outstanding, locally tailored user experience. Prior to this, Alibaba had already established its presence in the consumer-oriented (C-end) health services market through Tongyi Qianwen and Ant Aifu. Meanwhile, Ali Health took charge of developing applications for more serious medical scenarios. This move signifies Alibaba's comprehensive 'C+D' (Consumer + Doctor) end-to-end strategy in the healthcare sector.